|
Guardant Health Note11/1 (Principal)
|
6.7 |
$226M |
|
268M |
0.84 |
|
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
4.4 |
$148M |
|
141M |
1.05 |
|
Novocure Note11/0 (Principal)
|
4.0 |
$135M |
|
141M |
0.95 |
|
Neurocrine Biosciences
(NBIX)
|
3.6 |
$123M |
|
902k |
136.50 |
|
Repligen Corp Note 1.000%12/1 (Principal)
|
3.4 |
$115M |
|
112M |
1.02 |
|
Xenon Pharmaceuticals
(XENE)
|
3.4 |
$114M |
|
2.9M |
39.20 |
|
Nuvasive Note 0.375% 3/1 (Principal)
|
3.4 |
$113M |
|
114M |
0.99 |
|
Neogenomics Note 0.250% 1/1 (Principal)
|
2.9 |
$98M |
|
116M |
0.84 |
|
Legend Biotech Corp Sponsored Ads
(LEGN)
|
2.9 |
$97M |
|
3.0M |
32.54 |
|
Cg Oncology
(CGON)
|
2.8 |
$94M |
|
3.3M |
28.68 |
|
Guardant Health
(GH)
|
2.6 |
$87M |
|
2.8M |
30.55 |
|
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
|
2.5 |
$85M |
|
93M |
0.92 |
|
Align Technology
(ALGN)
|
2.3 |
$78M |
|
375k |
208.51 |
|
Dexcom Note 0.375% 5/1 (Principal)
|
2.2 |
$74M |
|
83M |
0.90 |
|
Apogee Therapeutics
(APGE)
|
2.1 |
$70M |
|
1.5M |
45.30 |
|
Kiniksa Pharmaceuticals Intl Ord Shs Cl A
(KNSA)
|
2.0 |
$68M |
|
3.5M |
19.78 |
|
Apellis Pharmaceuticals
(APLS)
|
2.0 |
$67M |
|
2.1M |
31.91 |
|
Irhythm Technologies
(IRTC)
|
1.9 |
$64M |
|
705k |
90.17 |
|
Edgewise Therapeutics
(EWTX)
|
1.8 |
$62M |
|
2.3M |
26.70 |
|
Day One Biopharmaceuticals I
(DAWN)
|
1.8 |
$62M |
|
4.9M |
12.67 |
|
Spyre Therapeutics Com New
(SYRE)
|
1.8 |
$60M |
|
2.6M |
23.28 |
|
Viking Therapeutics
(VKTX)
|
1.8 |
$60M |
|
1.5M |
40.24 |
|
Transmedics Group
(TMDX)
|
1.7 |
$58M |
|
922k |
62.35 |
|
Alphatec Hldgs Note 0.750% 8/0 (Principal)
|
1.6 |
$55M |
|
58M |
0.95 |
|
Inspire Med Sys
(INSP)
|
1.6 |
$54M |
|
293k |
185.38 |
|
Argenx Se Sponsored Adr
(ARGX)
|
1.5 |
$50M |
|
81k |
615.00 |
|
Thermo Fisher Scientific
(TMO)
|
1.4 |
$47M |
|
90k |
520.23 |
|
Bridgebio Pharma Note 2.250% 2/0 (Principal)
|
1.4 |
$46M |
|
54M |
0.86 |
|
Maravai Lifesciences Hldgs I Com Cl A
(MRVI)
|
1.3 |
$46M |
|
8.4M |
5.45 |
|
Sarepta Therapeutics
(SRPT)
|
1.3 |
$44M |
|
365k |
121.59 |
|
Penumbra
(PEN)
|
1.3 |
$44M |
|
184k |
237.48 |
|
Glaukos
(GKOS)
|
1.3 |
$43M |
|
289k |
149.94 |
|
Avadel Pharmaceuticals Com Shs
(AVDL)
|
1.3 |
$43M |
|
4.1M |
10.51 |
|
Repligen Corporation
(RGEN)
|
1.2 |
$41M |
|
284k |
143.94 |
|
Paragon 28
(FNA)
|
1.2 |
$40M |
|
3.8M |
10.33 |
|
Intuitive Surgical Com New
(ISRG)
|
1.2 |
$39M |
|
75k |
521.96 |
|
Alphatec Hldgs Com New
(ATEC)
|
1.2 |
$39M |
|
4.3M |
9.18 |
|
Biontech Se Sponsored Ads
(BNTX)
|
1.0 |
$35M |
|
310k |
113.95 |
|
Bicara Therapeutics
(BCAX)
|
1.0 |
$35M |
|
2.0M |
17.42 |
|
Krystal Biotech
(KRYS)
|
0.9 |
$31M |
|
201k |
156.66 |
|
Harrow Health
(HROW)
|
0.9 |
$30M |
|
907k |
33.55 |
|
Keros Therapeutics
(KROS)
|
0.9 |
$30M |
|
1.9M |
15.83 |
|
Oruka Therapeutics
(ORKA)
|
0.8 |
$27M |
|
1.1M |
23.61 |
|
Dianthus Therapeutics
(DNTH)
|
0.8 |
$26M |
|
1.2M |
21.80 |
|
Orthopediatrics Corp.
(KIDS)
|
0.8 |
$26M |
|
1.1M |
23.18 |
|
Immatics SHS
(IMTX)
|
0.7 |
$25M |
|
3.5M |
7.11 |
|
Geron Corporation
(GERN)
|
0.7 |
$25M |
|
7.0M |
3.54 |
|
Ironwood Pharmaceuticals Com Cl A
(IRWD)
|
0.7 |
$24M |
|
5.4M |
4.43 |
|
Bruker Corporation
(BRKR)
|
0.6 |
$21M |
|
353k |
58.62 |
|
EXACT Sciences Corporation
(EXAS)
|
0.6 |
$20M |
|
353k |
56.19 |
|
Nuvalent Inc-a
(NUVL)
|
0.6 |
$19M |
|
241k |
78.28 |
|
Vaxcyte
(PCVX)
|
0.5 |
$18M |
|
222k |
81.86 |
|
Replimune Group
(REPL)
|
0.5 |
$18M |
|
1.5M |
12.11 |
|
Dexcom Note 0.250%11/1 (Principal)
|
0.5 |
$18M |
|
19M |
0.97 |
|
Amphastar Pharmaceuticals In Note 2.000% 3/1 (Principal)
|
0.5 |
$16M |
|
17M |
0.94 |
|
Dyne Therapeutics
(DYN)
|
0.5 |
$16M |
|
681k |
23.56 |
|
Jasper Therapeutics Com New
(JSPR)
|
0.5 |
$15M |
|
715k |
21.38 |
|
Cullinan Oncology
(CGEM)
|
0.4 |
$14M |
|
1.2M |
12.18 |
|
Xencor
(XNCR)
|
0.4 |
$14M |
|
616k |
22.98 |
|
Candel Therapeutics
(CADL)
|
0.4 |
$14M |
|
1.6M |
8.68 |
|
Arcus Biosciences Incorporated
(RCUS)
|
0.4 |
$12M |
|
802k |
14.89 |
|
Celcuity
(CELC)
|
0.3 |
$12M |
|
884k |
13.09 |
|
4d Molecular Therapeutics In
(FDMT)
|
0.2 |
$6.8M |
|
1.2M |
5.57 |
|
Nevro
(NVRO)
|
0.2 |
$6.3M |
|
1.7M |
3.72 |
|
Zura Bio Class A Ord Shs
(ZURA)
|
0.2 |
$6.2M |
|
2.5M |
2.50 |
|
Ceribell
(CBLL)
|
0.2 |
$5.4M |
|
210k |
25.88 |
|
Pulmonx Corp
(LUNG)
|
0.2 |
$5.1M |
|
753k |
6.79 |
|
Aerovate Therapeutics
(AVTE)
|
0.1 |
$3.8M |
|
1.4M |
2.65 |
|
Cutera Note 4.000% 6/0 (Principal)
|
0.1 |
$2.6M |
|
29M |
0.09 |
|
Skye Bioscience Com New
(SKYE)
|
0.1 |
$2.3M |
|
826k |
2.83 |
|
Cutera Note 2.250% 6/0 (Principal)
|
0.1 |
$2.3M |
|
25M |
0.09 |
|
Protagonist Therapeutics
(PTGX)
|
0.0 |
$776k |
|
20k |
38.60 |
|
Miragen Therapeutics
(VRDN)
|
0.0 |
$654k |
|
34k |
19.17 |